Buscar
Alvotech SA
ALVOAñadir a la lista de seguimiento
4.120USD
+0.550+15.41%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.61BCap. mercado
42.76P/E TTM
Más Datos de Alvotech SA Compañía
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.
Información de Alvotech SA
Símbolo de cotizaciónALVO
Nombre de la empresaAlvotech SA
Fecha de salida a bolsaNov 09, 2020
Director ejecutivoWessman (Robert)
Número de empleados1011
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 09
Dirección9, Rue De Bitbourg
CiudadLUXEMBOURG
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísLuxembourg
Código postal1273
Teléfono35244224500
Sitio Webhttps://www.alvotech.com/
Símbolo de cotizaciónALVO
Fecha de salida a bolsaNov 09, 2020
Director ejecutivoWessman (Robert)
Ejecutivos de Alvotech SA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard John Davies
Mr. Richard John Davies
Non-Executive Independent Deputy Chairman of the Board
Non-Executive Independent Deputy Chairman of the Board
1.10M
+2.79%
Mr. Robert (Vilhelm) Wessman
Mr. Robert (Vilhelm) Wessman
Executive Chairman of the Board, Chief Executive Officer, Founder
Executive Chairman of the Board, Chief Executive Officer, Founder
320.00K
--
Ms. Ann Merchant
Ms. Ann Merchant
Non-Executive Independent Director
Non-Executive Independent Director
31.75K
+33.33%
Ms. Lisa Graver, J.D.
Ms. Lisa Graver, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
31.75K
+33.33%
Dr. Linda Mcgoldrick, Ph.D.
Dr. Linda Mcgoldrick, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
21.16K
+50.00%
Mr. Hjoerleifur Palsson
Mr. Hjoerleifur Palsson
Non-Executive Independent Director
Non-Executive Independent Director
7.12K
+66.98%
Ms. Tanya Zharov
Ms. Tanya Zharov
General Counsel
General Counsel
--
--
Mr. Joseph E. (Joe) Mcclellan
Mr. Joseph E. (Joe) Mcclellan
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Tomas Ekman
Mr. Tomas Ekman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Arni Hardarson
Mr. Arni Hardarson
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard John Davies
Mr. Richard John Davies
Non-Executive Independent Deputy Chairman of the Board
Non-Executive Independent Deputy Chairman of the Board
1.10M
+2.79%
Mr. Robert (Vilhelm) Wessman
Mr. Robert (Vilhelm) Wessman
Executive Chairman of the Board, Chief Executive Officer, Founder
Executive Chairman of the Board, Chief Executive Officer, Founder
320.00K
--
Ms. Ann Merchant
Ms. Ann Merchant
Non-Executive Independent Director
Non-Executive Independent Director
31.75K
+33.33%
Ms. Lisa Graver, J.D.
Ms. Lisa Graver, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
31.75K
+33.33%
Dr. Linda Mcgoldrick, Ph.D.
Dr. Linda Mcgoldrick, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
21.16K
+50.00%
Mr. Hjoerleifur Palsson
Mr. Hjoerleifur Palsson
Non-Executive Independent Director
Non-Executive Independent Director
7.12K
+66.98%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Alvotech SA?
Los cinco principales accionistas de Alvotech SA son: Mr. Richard John Davies
¿Cuántas instituciones poseen acciones de Alvotech SA (ALVO)?
A fecha de 2026Q1, 139 instituciones poseen acciones de Alvotech SA, con un valor de mercado combinado de aproximadamente 19.07M, lo que representa el 6.11% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2343174.00.